Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
- PMID: 8857751
- DOI: 10.1212/wnl.47.4.1085
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
Abstract
We studied the effect of olanzapine (1 to 15 mg/d) in 15 nondemented parkinsonian patients with drug-induced psychosis. Psychotic symptoms decreased significantly during treatment, and there was no worsening of extrapyramidal symptoms. These results suggest that olanzapine is a well-tolerated and effective treatment for drug-induced psychosis in nondemented patients with Parkinson's disease.
Comment in
-
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.Neurology. 1998 Apr;50(4):1195-6. doi: 10.1212/wnl.50.4.1195-a. Neurology. 1998. PMID: 9566437 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical